Published in Hepatitis Weekly, July 2nd, 2007
Dr. Kolk joins DermTech from Gen-Probe Inc. where for 12 years he was instrumental in the creation of multiple high-value molecular diagnostic products. Specifically, Dr. Kolk co-developed an assay that detects HIV-1 and HCV. That assay received FDA licensure in 2002 for use in blood screening and it is currently used to screen over 85% of all blood in the US for HIV-1 and HCV. He also co-developed the next generation version that included detection of HBV...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.